Call for Abstract

Global Summit on Oncology and Hematology, will be organized around the theme ““Advancements and Emerging Concepts in Oncology and Hematology Research””

Oncology Research 2020 is comprised of keynote and speakers sessions on latest cutting edge research designed to offer comprehensive global discussions that address current issues in Oncology Research 2020

Submit your abstract to any of the mentioned tracks.

Register now for the conference by choosing an appropriate package suitable to you.

Cancer Prevention is an achievement hauls towards lower possibility of getting disease. Cancer prevention is the practice of taking active measures to decrease the incidence of cancer and mortality. The practice of prevention is dependent upon both individual efforts to improve lifestyle and seek preventative screening and socioeconomic or public policy related to cancer prevention. Greater than a reported 75% of cancer deaths could be prevented by avoiding risk factors including: tobaccooverweight obesity, an insufficient diet, physical inactivityalcoholsexually transmitted infections, and air pollution.   Malignancy can be taken care of by numerous medications like chemotherapy, radiation treatment, hormonal treatment, target treatment, and palliative consideration.

 

  • Track 1-1Psychological Aspects
  • Track 1-2Hereditary Aspects
  • Track 1-3Food Habitats
  • Track 1-4Immunized Aspects
  • Track 1-5Chronic Inflammation

\r\n Hormonal therapy is the use of hormones in medical treatment. Treatment with hormone antagonists may also be referred to as hormonal therapy or antihormone therapy. Androgen replacement Therapy (ART), and transgender hormone therapy. In women, the body of the women is comprised of ovaries. Estrogen creates hormone receptor that prompts the positive bosom malignancy development. Subsequently, gathering the measure of estrogen can abbreviate the danger of an early life-arrange. In few cases, the medical procedure will goes about as a noteworthy job, for example, the ovaries just as the fallopian tubes reallocated by the careful technique so as to treat the hormone-receptor-positive bosom malignant growth. It is important to realize that hormonal treatment isn't hormone substitution treatment (HRT).

\r\n

\r\n  

\r\n

\r\n  

\r\n
  • Track 2-1LHRH Agonists
  • Track 2-2Oophorectomy
  • Track 2-3Aromatase Inhibitors
  • Track 2-4Side Effects of Hormonal Therapy
  • Track 2-5Role of Anti Androgens

\r\n Pathologists are among the most important members of a patient’s cancer care team. They work to diagnose and determine the stage of cancer, setting the course for what comes next in the treatment journey.. Pathologists are at the heart of cancer prevention through screening, diagnosis, monitoring and treatment. Pathology is the service that handles the blood samples and the cells and tissues removed from suspicious ‘lumps and bumps’. Cancer pathology’s key role in diagnosing and treating a complex disease, it’s important to stay up lumps and bumps to date on new technologies and breakthroughs that continue to shape the ever-evolving landscape of cancer care.

\r\n

\r\n  

\r\n
  • Track 3-1Anatomical Pathology
  • Track 3-2Oncopathology
  • Track 3-3Molecular pathology of cancer
  • Track 3-4Pathology in cancer diagnostics
  • Track 3-5Cancer Cytopathology
  • Track 3-6Pediatric pathology

\r\n Cancer stem cells (CSCs) are cancer cells that possess characteristics associated with normal stem cells, specifically the ability to give rise to all cell types found in a particular cancer sample. CSCs are therefore tumorigenic (tumor-forming), perhaps in contrast to other non-tumorigenic cancer cells. CSCs may generate tumors through the stem cell processes of self-renewal and differentiation into multiple cell types. Existing cancer treatments have mostly been developed based on animal models, where therapies able to promote tumor shrinkage were deemed effective. 

\r\n

\r\n  

\r\n
  • Track 4-1Cancer Stem Cells
  • Track 4-2Stem Cell Transplantation
  • Track 4-3Bone Marrow Transplantation
  • Track 4-4CSCs and Cancer Treatment

\r\n Recognizing cancer as a group of diseases caused by nanostructural problems (i.e. with DNA) and also that there are unique benefits to approaches inherently involving nanoscale structures and processes to treat the disease, the journal Cancer Nanotechnology aims to disseminate cutting edge research; to promote emerging trends in the use of nanostructures and the induction of nanoscale processes for the prevention, diagnosis, treatment of cancer; and to cover related ancillary areas. Cancer nanotechnology is a branch of nanotechnology concerned with the application of both nanomaterials and nanotechnology approaches to the diagnosis and treatment of cancer.

\r\n

\r\n  

\r\n
  • Track 5-1Cancer Microenvironment
  • Track 5-2Chemo Drugs
  • Track 5-3Stealth Nanoparticles and Tumor Penetrating Peptides
  • Track 5-4New Nanomaterials
  • Track 5-5Early Diagnosis and Imaging
  • Track 5-6Advances in Nanotechnology

\r\n Cancer cells keep growing without control. Chemotherapy is drug therapy for cancer. It works by killing the cancer cells, stopping them from spreading, or slowing their growth. However, it can also harm healthy cells, which causes side effects. Cancer can be treated by surgerychemotherapyradiation therapyhormonal therapytargeted therapy and synthetic lethality. Cancer genome sequencing helps in determining which cancer the patient exactly has for determining the best therapy for the cancer. A number of experimental cancer treatments are also under development. Under current estimates, two in five people will have cancer at some point in their lifetime

\r\n

\r\n  

\r\n
  • Track 6-1Treatment strategies
  • Track 6-2Adverse effects
  • Track 6-3Limitations
  • Track 6-4Cancer Therapeutics, Novel and experimental approaches

\r\n Neonatal & Pediatric Oncology is the term used to comprise all malignant conditions among neonates & children with cancer. The most common childhood cancers are, NeuroblastomaRetinoblastomaWilms tumor and brain tumors, such as gliomas. Childhood cancers are very rare and may differ from adult cancers in the way they grow, spread, treated, and respond to treatment. 

\r\n

\r\n  

\r\n
  • Track 7-1Pediatric Oncology Nursing
  • Track 7-2Integrative Pediatric Oncology
  • Track 7-3Palliative Care in Pediatric Oncology
  • Track 7-4Pioneers in pediatric oncology
  • Track 7-5Supportive Care in Pediatric Oncology
  • Track 7-6Fetal and Neonatal Pathology
  • Track 7-7Radiological Imaging of the Neonate

\r\n Ovarian Cancer is a type of cancer which occurs in one or two of the ovaries. This type of cancer often goes undetected until it is spread to pelvis and uterus at this stage it is much difficult to treat the cancer. Risk factors often include age, family history of cancer, inherited gene mutations, estrogen replacement therapy, age when mensuration started and ended. Ovarian cancer often goes undetected until it has spread within the pelvis and stomach. At this late stage, ovarian cancer is more difficult to treat and can be fatal. Ovarian cancer often has no symptoms in the early stages. Later stages are associated with symptoms, but they can be non-specific, such as loss of appetite and weight loss. Surgery and chemotherapy are generally used to treat ovarian cancer.

\r\n

\r\n  

\r\n
  • Track 8-1Epithelial tumors
  • Track 8-2Stromal tumors
  • Track 8-3Germ cell tumors

\r\n Oral disease is otherwise called mouth tumor. The oral growth may happen at any place in the mouth, on the surface of the tongue, on the lips, inside the cheek, in the gums, in the sense of taste of the mouth, in the salivary organs. Manifestations of oral disease incorporates; fixes on the coating of the mouth or tongue, mouth ulcers or wounds that don't recuperate, free teeth with obvious reason, jaw torment, excruciating tongue, change in voice, ear torment, sore throat and so forth and medicines for Oral growth are surgery, radiation treatment, chemotherapy.

\r\n

\r\n  

\r\n
  • Track 9-1Radiation Therapy
  • Track 9-2Chemotherapy
  • Track 9-3Pretreatment Dental Evaluation
  • Track 9-4Surgical Pathology of Oral Cancer
  • Track 9-5Oral and Maxillofacial Reconstruction

\r\n Contaminations in the female genitalia and the extra sex organs are regularly known as Gynecologic Infectious Diseases. A portion of the irresistible infections is Vulvovaginitis, Cervicitis, Pelvic Inflammatory Diseases, and Sexually Transmitted Diseases. Gynecologic Oncology is a specific field that arrangements with growths relating to the female genitalia and conceptive framework. Ovarian malignancy, uterine disease, vaginal growth, cervical tumor, and vulvar disease are each of the pieces of gynecologic oncology.

\r\n

\r\n  

\r\n
  • Track 10-1Through direct contact with a person who is sick.
  • Track 10-2• Through indirect contact, when you touch something that has germs on it.
  • Track 10-3Through insect or animal bites
  • Track 10-4Through contaminated food, water, soil, or plants

\r\n A hormone-receptor-positive (HR+) tumor is a tumor which consists of cells that express receptors for certain hormones. The term most commonly refers to estrogen receptor positive estrogen receptor positive tumors  (i.e. tumors that contain estrogen receptor positive cells), but can also include progesterone receptor positive tumors. Estrogen-receptor-positive tumors depend on the presence of estrogen for ongoing proliferation.

\r\n

\r\n  

\r\n

\r\n  

\r\n
  • Track 11-1Lowering systemic levels of estrogen.
  • Track 11-2Achieved by the use of drugs from the aromatase inhibitor category.
  • Track 11-3Blockage of the estrogen receptors on the cancerous cells
  • Track 11-4Treating hematological malignancies such as lymphoma and leukemia (cancers)
  • Track 11-5The science of blood transfusion and the work of a blood bank

\r\n The finding of treatment and counteractive action of blood illnesses (hematology) and malignancy (oncology) and investigation in them. Hematology-oncology incorporates such sicknesses as iron lack paleness, hemophiliasickle cell illness, the thalassemias, leukemias and lymphomas, and in addition tumors of different organs.

\r\n

\r\n  

\r\n
  • Track 12-1Treating bleeding disorders such as hemophilia and idiopathic Thrombocytopenic purpura
  • Track 12-2Treating Hemoglobinopathies
  • Track 12-3Bone marrow and stem cell transplantation
  • Track 12-4Processing and testing
  • Track 12-5Compatibility testing
  • Track 12-6Infection

\r\n Blood transfusion is a process in which donated blood/blood products are transferred into one’s circulation intravenously. This is a potentially lifesaving procedure used for various medical conditions to replace the lost components of blood due to surgery or injury. However, minor to severe problems do occur occasionally. Most common complications include allergic reactions, blood-borne infections, fever, acute immune hemolytic reaction

\r\n

\r\n  

\r\n
  • Track 13-1Blood donation
  • Track 13-2Immunologic reaction
  • Track 13-3Compatibility testing
  • Track 13-4Infection

\r\n The umbilical cord is a conduit between the developing embryo or fetus and the placenta. The umbilical vein supplies the fetus with  nutrient-rich blood from the placenta The hematopoietic bone marrow transplant, the HSC are removed from a large bone of the donor, typically the pelvis, through a large need let that reaches the center of the bone. Acute myeloid leukemia is a cancer of the myeloid line of blood cells, characterized by the rapid growth of abnormal white blood cells that accumulate in the bone marrow and interfere with the production of normal blood cells and the Thrombosis is the formation of a blood clot inside a blood vessel, obstructing the flow of blood through the circulatory system. The Hemostatic is a process which causes bleeding to stop, meaning to keep blood within a damaged blood vessel this is the first stage of wound healing.

\r\n

\r\n  

\r\n
  • Track 14-1Venous thrombosis
  • Track 14-2Platelet activation
  • Track 14-3Normal blood cells

\r\n Oncology Nursing is a field including practice incorporates the jobs of direct guardian, instructor, specialist Hematology & Oncology Nursing:, head, and scientist. Oncology nursing care can defined as meeting the various needs of oncology patients during the time of their disease including appropriate screenings and other preventative practices, symptom management, care to retain as much normal functioning as possible, and supportive measures upon end of life. Often abbreviated to Heme/Onc Nurses are those individuals who work with patient populations undergoing both solid and bloodborne cancer diagnoses, treatment and remission.Management & Palliative Care

\r\n

\r\n  

\r\n
  • Track 15-1Assessing Physical & Emotional Status
  • Track 15-2Treatment Plans
  • Track 15-3Symptom Management
  • Track 15-4Supportive Care
  • Track 15-5Direct Patient Care

Many factors impact the development of cancer. Over the last 25 years, science has displayed that diet, body weight and physical activity —especially being overweight or obese—are leading risk factors for obtaining certain types of cancer. The main behavioral and environmental risk factors for cancer death in the world are related to diet and physical inactivity, use of addictive substances, sexual and reproductive health and exposure to air pollution and use of contaminated needles. The body’s ability to confront cancer may be helped by succeeding a healthy diet, staying physically active, and escaping excess body fat. Cancer and cancer treatments can also alter your body's ability to tolerate certain foods and use nutrients.

 

  • Track 16-1Lifestyle Factors
  • Track 16-2Combined Impact
  • Track 16-3Population Attributable Risks
  • Track 16-4Investigation into Cancer and Nutrition (EPIC)

\r\n Cancer immunology is a stream of immunology that studies communications between the immune system and cancer cells (also called tumors or malignancies). It is a field of research that intent to discover cancer immunotherapies to treat and decelerate evolution of the disease. The human immune system mounts natural endogenous response to foreign cells. The gamut of genetics and epigenetics changes occurring in tumors provides diverse set of antigenic repertoire that host’s immune system can exploit to distinguish tumour versus their normal healthy counterparts. The immune response, including the detection of cancer-specific antigens, forms the basis of targeted therapy (such as vaccines and antibody therapies) and tumor marker-based diagnostic tests.

\r\n

\r\n  

\r\n
  • Track 17-1Host-Tumor Relation
  • Track 17-2Clinical Cancer immunology
  • Track 17-3Cancer Antigens & Vaccines
  • Track 17-4Cellular Immunotherapy
  • Track 17-5Antibody Therapy
  • Track 17-6Antibody Therapy
  • Track 17-7Cytokine Therapy
  • Track 17-8Combination & Combinatorial Ablation and Immunotherapies

The worldwide market of thehematological medications in top point as it is frequently anticipated to be enhanced over the couple of decades. As per the worldwide market expert the haematology medicate and demonstrative market is relied upon to develop at the rate of 7.5% from 2015-2020.

Biological Drugs and oncology, Bristol-Mayers Squibb, Bristol-Myers Squibb, Boehringer Ingelheim, Roche, Novartis, Celgene, Johnson and Johnson, Lilly, Takeda, 

  • Track 18-1Biological drugs
  • Track 18-2Generic drugs
  • Track 18-3Increased investments
  • Track 18-4Healthcare expenditures

A cancer biomarker indicates to a substance or process that symbolizes the presence of cancer in the body. A biomarker might be a molecule secreted by a tumor or a specific response of the body to the presence of cancer. Genetic, epigenetic, proteomic, glycomic, and imaging biomarkers can be preferred for cancer diagnosis, prognosis, and epidemiology. A cancer biomarker refers to a substance that indicates the presence of cancer in the body. A biomarker may be a molecule produced by a tumor or a specific response of the body to the presence of cancer. Epigenetic, proteomic, genetic, glycomic and imaging biomarkers can be used for cancer diagnosis, prognosis and epidemiology.

 A cancer biomarker refers to a substance or process that is indicative of the presence of cancer in the body. A biomarker may be a molecule secreted by a tumor or a specific response of the body to the presence of cancer, The most vital use of biomarkers today is to diagnose which therapies a patient’s cancer may or may not respond to

 

  • Track 19-1Predictive & Prognostic Biomarkers
  • Track 19-2Companion Biomarker
  • Track 19-3Patient Assessment & Education
  • Track 19-4Forensic Pathology
  • Track 19-5Molecular Cancer Biomarkers
  • Track 19-6Predictive & Prognostic Biomarkers